Vinorelbine in Treating Children With Recurrent or Refractory Cancers
- Conditions
- Interventions
- First Posted Date
- 2003-10-28
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 50
- Registration Number
- NCT00003234
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Valley Children's Hospital, Madera, California, United States
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
- Conditions
- Interventions
- Biological: filgrastimBiological: sargramostimDrug: carboplatinDrug: cisplatinDrug: cyclophosphamideDrug: doxorubicin hydrochlorideDrug: etoposideDrug: etoposide phosphateDrug: ifosfamideDrug: isotretinoinDrug: melphalanDrug: thiotepaDrug: vincristine sulfateProcedure: conventional surgeryProcedure: peripheral blood stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2003-10-09
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 42
- Registration Number
- NCT00017368
- Locations
- 🇺🇸
CCOP - Columbia River Oncology Program, Portland, Oregon, United States
🇺🇸Floating Hospital for Children, Boston, Massachusetts, United States
🇺🇸CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 50
- Registration Number
- NCT00070109
- Locations
- 🇺🇸
Childrens Memorial Hospital, Chicago, Illinois, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
🇨🇦Hospital for Sick Children, Toronto, Ontario, Canada
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
- Conditions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2014-02-20
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 33
- Registration Number
- NCT00070473
- Locations
- 🇺🇸
SUNY Upstate Medical University Hospital, Syracuse, New York, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
- Conditions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2014-02-20
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 350
- Registration Number
- NCT00070174
- Locations
- 🇺🇸
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸St. Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸All Children's Hospital, St. Petersburg, Florida, United States
Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
- Conditions
- Interventions
- Biological: filgrastimDrug: cisplatinDrug: cyclophosphamideDrug: doxorubicin hydrochlorideDrug: etoposideDrug: isotretinoinDrug: melphalanDrug: topotecan hydrochlorideDrug: vincristine sulfateProcedure: conventional surgeryProcedure: peripheral blood stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 31
- Registration Number
- NCT00070200
- Locations
- 🇺🇸
Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, United States
🇺🇸Children's Memorial Hospital - Chicago, Chicago, Illinois, United States
🇦🇺Westmead Hospital, Westmead, New South Wales, Australia
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
- Conditions
- Interventions
- Biological: aldesleukinBiological: filgrastimBiological: recombinant interferon gammaDrug: carmustineDrug: cyclosporineDrug: cytarabineDrug: etoposideDrug: melphalanProcedure: autologous bone marrow transplantationProcedure: bone marrow ablation with stem cell supportProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2013-10-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 24
- Registration Number
- NCT00070187
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸Children's Hospital of Minnesota - Minneapolis, Minneapolis, Minnesota, United States
Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 33
- Registration Number
- NCT00070304
- Locations
- 🇺🇸
St. Barnabas Medical Center Cancer Center, Livingston, New Jersey, United States
🇺🇸Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
- Conditions
- Interventions
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 70
- Registration Number
- NCT00068419
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
Interferon Alfa in Treating Children With HIV-Related Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-08-11
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 8
- Registration Number
- NCT00002621
- Locations
- 🇺🇸
Mission Saint Joseph's Health System, Asheville, North Carolina, United States
🇺🇸Via Christi Regional Medical Center, Wichita, Kansas, United States
🇺🇸Tomorrows Children's Institute, Hackensack, New Jersey, United States